Pulmonary hypertension (PH) frequently complicates the course of patients with various
forms of chronic lung disease (CLD). CLD-associated PH (CLD-PH) is invariably associated …

Pulmonary hypertension (PH) because of chronic lung disease is categorized as Group 3
PH in the most recent classification system. Prevalence of these diseases is increasing over …

Pulmonary hypertension (PH) developing secondarily in pulmonary fibrosis (PF) patients
(PF-PH) is a frequent co-morbidity. The high prevalence of PH in PF patients is very …

Background Pulmonary hypertension (PH) is a common complication of interstitial lung
disease (ILD) and is associated with worse outcomes and increased mortality. Evaluation of …

Pulmonary hypertension (PH) is a frequent and important complication of chronic obstructive
pulmonary disease (COPD). It is associated with worse clinical courses with more frequent …

Pulmonary hypertension (PH) complicates the treatment of interstitial lung disease (ILD)
patients resulting in poor functional status and worse outcomes. Early recognition of PH in …

Pulmonary hypertension in interstitial lung disease: screeni... : Current Opinion in
Pulmonary Medicine Pulmonary hypertension in interstitial lung disease: screening …

Background and objective Elevated mean pulmonary artery pressure (mPAP) is a significant
prognostic indicator in idiopathic pulmonary fibrosis (IPF). It has been reported that the …

Background and objective In interstitial lung disease (ILD), pulmonary hypertension (PH) is
a major adverse prognostic determinant. Transthoracic echocardiography (TTE) is the most …

Pulmonary hypertension (PH) associated with chronic lung disease (CLD) is both common
and underrecognised. The presence of PH in the setting of lung disease has been …